Please assess the completion status of the following clinical trial:

Trial Title: Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages: 10-80 years~* Clinical diagnosis of inflammatory dermatoses such as atopic dermatitis, psoriasis, mycosis fungoides, alopecia areata, and urticaria.~* No disease states or physical conditions that would impair evaluation of the test site.~* Willing and able to receive UVA1 or UVB, as directed in the protocol; make evaluation visits; and follow protocol restrictions.~* Signed, written, witnessed, informed consent form.~* Must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study.~Exclusion Criteria:~* History of photosensitivity (development of hives or bumps with exposure to light).~* UVA1 or UVB irradiation hypersensitivity in a UVA1/UVB photo-provocation test.~* Pregnant or nursing women.~* Involved in an investigational study within the previous 4 weeks.~* Presence of bacterial superinfection.~* Taken oral therapy for skin condition within the last 4 weeks~* Topical steroid therapy within the last 2 weeks~* History of excessive scar formation or keloids

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- UVA1 Irradiation (Type: EXPERIMENTAL): UVA 1 Irradiation (Sellemed UVA1 light source) up to 130 J/cm2
- UVB Irridiation (Type: EXPERIMENTAL): UVB Irradiation maximum dose of 4000 mJ/cm2

Based on this trial design, predict the completion outcome and termination type (if applicable).